SeaStar Medical Holding Corporation

SeaStar Medical Holding Corporation

ICU ·

SeaStar Medical Holding Corporation (ICU) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for SeaStar Medical Holding Corporation in 2026. The next earnings report is expected on November 18, 2026.

Earnings calendar

Next earnings date

18 Nov 2026

In 90 days

EPS estimate

-0.90

Revenue estimate

450.5K

Past earnings

12 Aug 2026
EPS actual
-0.91 (+6.2%)
estimate -0.97
Revenue actual
615.0K (+26.4%)
estimate 486.5K
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
13 May 2026
EPS actual
-0.90 (-9.1%)
estimate -0.83
Revenue actual
495.0K (+13.1%)
estimate 437.5K
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

SeaStar Medical Holding Corporation beat consensus estimates in its latest earnings report, with EPS of $-0.91 versus an estimate of $-0.97 and revenue of $615 thousand exceeding estimates by 26.4%. In the prior report EPS missed expectations while revenue came in ahead of estimates.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is based in Denver, Colorado.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
Nasdaq
CEO
Eric Schlorff
Employees
19
IPO date
18 Mar 2021
ISIN
US81256L3024
Website
seastarmedical.com

Frequently asked questions

When does SeaStar Medical Holding Corporation (ICU) next report earnings?

SeaStar Medical Holding Corporation (ICU) is scheduled to report earnings on November 18, 2026.

What was SeaStar Medical Holding Corporation's most recent earnings date?

SeaStar Medical Holding Corporation (ICU) last reported earnings on August 12, 2026.

Where is SeaStar Medical Holding Corporation stock listed?

SeaStar Medical Holding Corporation (ICU) is listed on Nasdaq.